Divi’s Lab Q4 2026 Results: PAT Rises 13% YoY, Recommends ₹30 Dividend

Pharma research icons and growth charts analyzing the Divis Lab Q4 2026 result expectations and profit margins.

Quick Summary

Divi’s Lab Q4 2026 Results: The company reported consolidated revenue from operations of ₹2,831 crore, up 9.52% YoY and 8.72% QoQ. PAT rose 13.44% YoY to ₹751 crore. The board recommended a final dividend of ₹30 per share for FY26.

Divi’s Lab Q4 2026 Results: On 23 May 2026, Divi’s Laboratories reported its Q4 FY26 results. The company’s net profit rose 13.57% YoY and nearly 28.8% QoQ. Divi’s Laboratories posted steady growth in the March quarter, driven by higher revenue and improved profitability. 

Divi’s Lab Q4 2026 Results Highlights

Divi’s Lab consolidated revenue and profit increased on both a yearly and quarterly basis, supported by higher forex gains during the quarter. Here are the key highlights of Divi’s Lab Q4 FY26 results.

Divi's Lab Q4 2026 Results Highlights, showing all the numbers

Source: NSE filing, Divi’s Laboratories FY26 Consolidated Annual Results

Divi’s Laboratories reported consolidated revenue from operations of ₹2,831 crore in Q4 FY26, compared with ₹2,585 crore in Q4 FY25, registering a growth of 9.52% year-on-year. Revenue increased 8.72% from Q3 FY26.

Total income for the quarter stood at ₹2,986 crore, up 11.79% from ₹2,671 crore in the same quarter last year. On a quarter-on-quarter basis, total income rose 10.92%.

Higher other income and forex gains supported overall earnings growth during the quarter. The company reported forex gain of ₹90 crore in Q4 FY26 against ₹10 crore in Q4 FY25.

Consolidated profit after tax stood at ₹751 crore in Q4 FY26, compared with ₹662 crore in Q4 FY25, reflecting a rise of 13.44% year-on-year. PAT jumped 28.82% from Q3 FY26. 

Earnings per share increased to ₹28.31 from ₹24.93 in the year-ago quarter.

Divi’s Lab Full-Year Performance Remained Strong

For the full financial year FY26, Divi’s Laboratories reported consolidated revenue from operations of ₹10,560 crore, compared with ₹9,360 crore in FY25. Profit after tax rose to ₹2,568 crore from ₹2,191 crore in the previous year. The company said profit before tax for FY26 included an exceptional impact of ₹74 crore related to labour code changes.

Divi's Lab Full-Year Performance Remained Strong

Source: NSE filing, Divi’s Laboratories FY26 Consolidated Annual Results

Divi’s Laboratories Dividend 2026 and Stock Performance

Divi’s Laboratories announced a final dividend of ₹30 per equity share of face value ₹2 each for FY26. The dividend payout is subject to shareholder approval at the 36th Annual General Meeting scheduled on 10 August 2026. The company fixed July 24, 2026 as the record date for dividend eligibility.

Divi’s Lab shares closed 0.61% higher on Friday. On a year-to-date (YTD) basis, Divis lab share price has gained nearly 9%. Over the one-year period from 23 May 2025 to 23 May 2026, Divi’s Lab share price rose around 7%. In five-year from 23 May 2021 to 23 May 2026, Divis Labs tock surged nearly 69%.

Read this also: All about Life Cycle Funds

About Author: Hemant Bisht

Hemant Bisht is the Founder of Trade Target and an experienced capital markets professional with over a decade of expertise in equities, mutual funds, and investment research. He focuses on delivering data-driven analysis and structured financial insights that support informed decision-making for today’s investors.